Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

History of Changes on the ClinicalTrials.gov Archive Site

Information in a ClinicalTrials.gov record can be modified at any time by the data provider.
The display at ClinicalTrials.gov shows the most recent version for each data element.
The full history of changes since the record was first received is available in the
archival version of the record on the ClinicalTrials.gov Archive Site.

ClinicalTrials.gov Identifier: NCT02484404
Study Title: Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody MEDI4736 in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers
First Submitted: June 25, 2015
Last Update Posted: March 13, 2020
Continue to the history of changes for this study on the